SCHEDULE 13G/A: Todd W. Fennell Discloses 8.5% Beneficial Stake in Prothena Corp
Beneficial Ownership Disclosure
Todd W. Fennell has filed an amended Schedule 13G, disclosing beneficial ownership of 8.5% of Prothena Corp Public Ltd Co's Ordinary Shares as an independent trustee.
Summary
- Todd W. Fennell reported beneficial ownership of 4,590,805 Ordinary Shares of Prothena Corp Public Ltd Co as of March 31, 2025.
- This stake represents approximately 8.5% of the company's total outstanding Ordinary Shares.
- The shares are held across various irrevocable gift trusts (492,459 shares) and grantor retained annuity trusts (4,098,346 shares), for which Mr. Fennell serves as an independent trustee.
- Mr. Fennell holds shared voting power and shared dispositive power over all 4,590,805 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 240.14a-11.
Sentiment
Score: 5
Explanation: This is a routine Schedule 13G filing disclosing a significant beneficial ownership stake, which is neutral in sentiment as it does not convey positive or negative operational or financial news.
Future Outlook
No forward-looking statements or guidance regarding the company's future performance or strategy are provided in this beneficial ownership disclosure.
Industry Context
This filing is a routine disclosure of a significant beneficial ownership stake in Prothena Corp, providing transparency on the company's ownership structure rather than insights into broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Provides increased transparency regarding a significant beneficial owner's stake in the company, clarifying the ownership structure.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Date of Limited Power of Attorney granted by Todd W. Fennell for the signing of SEC filings. |
| 02/20/2025 | Date as of which Prothena Corp Public Ltd Co reported 53,826,982 Ordinary Shares outstanding in its most recent Annual Report on Form 10-K. |
| 03/31/2025 | Date of the event which required the filing of this Schedule 13G statement. |
| 05/15/2025 | Date the Schedule 13G statement was signed. |
Keywords
Prothena Corp, Todd W. Fennell, Schedule 13G, beneficial ownership, Ordinary Shares, institutional investor, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.